[go: up one dir, main page]

IS5558A - Aðferð til að framleiða doxasósínmesýlat í kristallstilbrigði sem er vísað til sem form A og milliefni þess - Google Patents

Aðferð til að framleiða doxasósínmesýlat í kristallstilbrigði sem er vísað til sem form A og milliefni þess

Info

Publication number
IS5558A
IS5558A IS5558A IS5558A IS5558A IS 5558 A IS5558 A IS 5558A IS 5558 A IS5558 A IS 5558A IS 5558 A IS5558 A IS 5558A IS 5558 A IS5558 A IS 5558A
Authority
IS
Iceland
Prior art keywords
mesylate
doxasosin
intermediates
producing
methanol
Prior art date
Application number
IS5558A
Other languages
English (en)
Inventor
Klein Peter
Thyes Marco
Hix Dieter
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Publication of IS5558A publication Critical patent/IS5558A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5558A 1998-01-06 2000-07-05 Aðferð til að framleiða doxasósínmesýlat í kristallstilbrigði sem er vísað til sem form A og milliefni þess IS5558A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19800214A DE19800214A1 (de) 1998-01-06 1998-01-06 Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
PCT/EP1998/008360 WO1999035143A1 (de) 1998-01-06 1998-12-18 Verfahren zur herstellung von doxazosin-mesylat in einer als form a bezeichneten kristallmodifikation und ein zwischenprodukt für deren herstellung
CZ20002403A CZ20002403A3 (cs) 1998-01-06 1998-12-18 Způsob přípravy doxazosinmesylátu v krystalické modifikaci, označované jako forma A a meziprodukt pro tento způsob

Publications (1)

Publication Number Publication Date
IS5558A true IS5558A (is) 2000-07-05

Family

ID=37719223

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5558A IS5558A (is) 1998-01-06 2000-07-05 Aðferð til að framleiða doxasósínmesýlat í kristallstilbrigði sem er vísað til sem form A og milliefni þess

Country Status (16)

Country Link
US (1) US6500830B1 (is)
EP (1) EP1060177B1 (is)
JP (1) JP2002500223A (is)
CN (1) CN1285829A (is)
AT (1) ATE335736T1 (is)
AU (1) AU2275199A (is)
CA (1) CA2317523A1 (is)
CZ (1) CZ20002403A3 (is)
DE (3) DE19800214A1 (is)
ES (1) ES2268812T3 (is)
HU (1) HUP0100716A2 (is)
IL (1) IL137003A0 (is)
IS (1) IS5558A (is)
SI (1) SI1060177T1 (is)
TR (1) TR200001910T2 (is)
WO (1) WO1999035143A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
DE19912063A1 (de) * 1999-03-18 2000-09-21 Knoll Ag Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation
DE19912573A1 (de) * 1999-03-19 2000-09-21 Knoll Ag Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D
RU2186779C1 (ru) * 2001-01-31 2002-08-10 Федеральное государственное унитарное предприятие Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения метансульфоната доксазозина
EP1530047A1 (en) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximal markers of arterial thrombosis and inflammation for risk stratification of coronary heart disease
AU2008339652B2 (en) * 2007-12-24 2013-07-04 Cipla Limited Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof
CN109988158A (zh) * 2018-01-03 2019-07-09 合肥立方制药股份有限公司 X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途
CN111303130B (zh) * 2018-12-11 2021-09-14 合肥立方制药股份有限公司 一种多沙唑嗪甲磺酸盐晶型、其制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
DK0459666T3 (da) 1990-05-31 1994-12-05 Pfizer Lægemidler mod impotens
WO1994009783A1 (en) * 1992-11-04 1994-05-11 Sepracor, Inc. Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
DE69503066T2 (de) 1995-06-06 1998-10-15 Pfizer Inc., New York, N.Y. KRISTALLFORM VON WASSERFREIEN 7-((1a,5a,6a)-6-AMINO-3-AZABICYCLO (3.1.0.) HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDIN-CARBONSÄURE METHANESULFONSÄURE SALZ
IT1287588B1 (it) 1996-12-13 1998-08-06 Alfa Chem Ital Forma cristallina del doxazosin mesilato e processo per la sua produzione
EP0849265A1 (de) 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
PT849266E (pt) 1996-12-20 2007-03-30 Heumann Pcs Gmbh Nova forma polimorfa de mesilato de doxazosina (forma iii)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)

Also Published As

Publication number Publication date
US6500830B1 (en) 2002-12-31
EP1060177A1 (de) 2000-12-20
ATE335736T1 (de) 2006-09-15
AU2275199A (en) 1999-07-26
IL137003A0 (en) 2001-06-14
JP2002500223A (ja) 2002-01-08
CN1285829A (zh) 2001-02-28
HUP0100716A2 (hu) 2002-05-29
SI1060177T1 (sl) 2006-12-31
DE29824265U1 (de) 2001-04-26
TR200001910T2 (tr) 2000-11-21
DE59813681D1 (de) 2006-09-21
DE19800214A1 (de) 1999-07-15
CZ20002403A3 (cs) 2000-12-13
WO1999035143A1 (de) 1999-07-15
ES2268812T3 (es) 2007-03-16
CA2317523A1 (en) 1999-07-15
EP1060177B1 (de) 2006-08-09

Similar Documents

Publication Publication Date Title
CL2010000436A1 (es) Proceso para preparar bisulfato del ester etilico del acido 9-[2-[5-(3-fluorofenil)-piridin-2-il]-vinil]-1-metil-3-oxo-dodecahidro-nafto[2,3-c]furan-6-il-carbamico, util en el tratamiento de trombosis, aterosclerosis, restenosis, hipertension, arritmia, cancer. (divisional de solicitud 15-2005).
MY170957A (en) Method for producing lignin degradation product
NZ509798A (en) Process for preparing omeprazole
DE60009326D1 (de) Verfahren zur herstellung von silicoaluminophosphat-molekularsieben
IS5558A (is) Aðferð til að framleiða doxasósínmesýlat í kristallstilbrigði sem er vísað til sem form A og milliefni þess
NO20021336L (no) Gjenvinningsprosess av flyktige forbindelser fra faststoffer i en vandig opplösning
ATE423778T1 (de) Verfahren zur herstellung von anthranilsäurederivat-hydrat
ES2192165T3 (es) Metodo para preparar cristales en forma ii de claritromicina de la forma ii.
EP1325943A3 (en) A method for the production of a lutein-fatty acid ester concentrate
CA2325919A1 (en) Processes for the preparation of threo-1,2-epoxy-3-amino-4-phenylbutane derivatives
IL178046A0 (en) An improved process for producing chlorinated sucrose
DE50001574D1 (de) Verfahren zum dehydratisieren von biologischen geweben zur herstellung von transplantat-konserven
DE60015984D1 (de) Verfahren zum gewinnen von organischen säuren
KR20010022595A (ko) 엘-아스코브산의 제조 방법
ATE259366T1 (de) Herstellungsverfahren für ein bekanntes terazolderivat
CN104829590B (zh) 一种纯化曲格列汀的方法
RU2006102357A (ru) Способ управления кристаллической структурой ризедроната
ATE297933T1 (de) Ein verfahren zur herstellung von hochreinem cefpodoxim-proxetil
KR100367722B1 (ko) 초음파 전처리와 열수 추출에의한 수용성 저분자 알긴산의제조방법
CN102964355B (zh) 一种青霉素g亚砜的制备方法
CN115010646B (zh) 一种吲哚酮类化合物的光诱导合成方法
EA200500188A1 (ru) Кристаллические формы оланзапина и способы их получения
ATE403658T1 (de) Verfahren zur herstellung einer lösung von reinem triethylendiamin (teda)
ATE469149T1 (de) Verfahren zur herstellung von cabergolin
ES2164520A1 (es) "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"